Zevra Therapeutics, Inc. (ZVRA)
8.575
-0.20
(-2.33%)
USD |
NASDAQ |
Dec 09, 16:00
8.51
-0.06
(-0.76%)
After-Hours: 20:00
Zevra Therapeutics Shareholders Equity (Quarterly): 133.16M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Nektar Therapeutics | 85.09M |
| XOMA Royalty Corp. | 107.96M |
| Akebia Therapeutics, Inc. | 41.59M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
| Palatin Technologies, Inc. | 0.3964M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 270.12M |
| Total Liabilities (Quarterly) | 136.95M |
| Debt to Equity Ratio | 0.471 |
| Current Ratio | 8.621 |
| Net Debt Paydown Yield | -0.12% |